Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Elamipretide for Sale > High Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide
High  Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide buy - large image1
High  Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide buy - image1
High  Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide buy - image2
High  Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide buy - image3
High  Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide buy - image4
High  Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide buy - image5
High  Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide buy - image6

High Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide

TDS 105 Inquiries

Unit Price:

$81/UNIT FOB

Get Latest Price
CAS No.:

736992-21-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Hongkong

Brand:

Novio

Packaging:

10mg*10vials, 50mg*10vials

Sample Available:

Yes

Price valid (until):

2028-01-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    WhatsApp +852 9339 8574
    SS-31 is a synthetic small-molecule peptide with mitochondria-targeting properties, representing a highly promising candidate in the field of mitochondrial function protection. Unlike bioactive peptides that act on the cell surface or periphery, SS-31 is unique in its ability to precisely reach—and function within—mitochondria, the critical sites of cellular energy production. Stable mitochondrial function is fundamental to maintaining overall metabolic and physiological health; SS-31 is specifically designed to preserve this function. By targeting mitochondria to safeguard energy production, it occupies a distinctive position in research spanning metabolic science, cell biology, and physiological maintenance.
    In terms of its mechanism of action, SS-31 primarily functions by protecting mitochondrial integrity. During energy production, mitochondria generate various reactive species; while these participate in signaling regulation at normal levels, their excessive accumulation can cause oxidative damage to mitochondrial structures, thereby impairing the efficiency and stability of energy production. SS-31 precisely targets the mitochondrial membrane to modulate oxidative stress, helping to buffer the impact of excess reactive species and thus preserving mitochondrial structural integrity and energy-generating capacity. This "target-the-source, protect-the-core" mechanism offers a uniquely targeted approach to maintaining energy metabolism.
    SS-31 demonstrates significant value in the maintenance of energy metabolism. As the primary site of cellular energy production, mitochondrial function directly influences the body's energy supply and metabolic balance. By protecting mitochondrial function, SS-31 helps sustain efficient and stable energy production, providing a solid energy foundation for the proper functioning of the body's various systems. Research indicates that SS-31’s effects are frequently linked to improved energy metabolic status, highlighting its potential to support energy metabolism and physiological health. This protective mechanism—focusing on the source of energy production—distinguishes it from interventions acting on peripheral pathways and reflects a more fundamental approach to metabolic maintenance.
    SS-31 also holds significant research value regarding the regulation of oxidative stress. Reactive species are naturally produced during normal physiological processes, and maintaining a balance between oxidation and reduction is crucial for cellular functional stability. The excessive accumulation of reactive species can damage cellular structures and impair normal function. By modulating oxidative stress at the mitochondrial level, SS-31 helps maintain redox balance and protects mitochondria—a critical cellular structure—from damage, thereby preserving overall functional stability. This mechanism of "maintaining balance at the source" gives it unique value in the fields of antioxidant research and functional preservation.
    SS-31 has garnered sustained interest in research concerning the maintenance of physiological function. Mitochondrial function is not only essential for energy production but is also closely linked to the proper operation of various bodily functions. Studies indicate that by protecting mitochondrial function, SS-31 may positively influence a range of energy-dependent physiological processes, helping to maintain overall stability and efficiency. While these areas remain largely in the exploratory research phase—requiring further study to confirm specific effects and scopes of application—they highlight the vast potential of SS-31 as a mitochondrial-protective molecule.
    Regarding its application characteristics, SS-31 is a synthetic targeted peptide offering distinct advantages: a well-defined structure, precise targeting capabilities, and controllable purity. Its molecular structure is optimized to reach mitochondria specifically, enabling targeted functional regulation. Furthermore, its mature synthesis process ensures product standardization and consistency, facilitating systematic research and development. These attributes—precision, structural clarity, and controllability—make it highly suitable for mitochondrial research and provide a solid foundation for further investigation.
    Regarding safety, it is important to view the current status of SS-31 objectively. As a research-grade peptide, SS-31 is primarily used in laboratory studies, mitochondrial biology research, and related application development; it has not yet received full regulatory approval or commercial launch as a finished product globally. Observed effects stem largely from specific experimental conditions, with outcomes closely tied to factors such as dosage and individual physiological status. Consequently, any research or application must be grounded in a comprehensive understanding and rigorous assessment, adhering to scientific principles to avoid indiscriminate use. Research teams continue to conduct assessments to deepen the understanding of its mechanisms and effects. From an industry perspective, SS-31 represents a research direction focused on "targeting mitochondria to protect the energy core." Its approach—combining precision targeting technology with the preservation of mitochondrial function—offers a fresh perspective on research into metabolic and physiological maintenance. Unlike compounds with broad-spectrum effects or complex mechanisms, SS-31 is characterized by clear targeting, protection at the source, and focused action, aligning with the modern life sciences' pursuit of precision. As mitochondrial biology advances and targeted peptide technology evolves, the potential value of SS-31 in areas such as energy metabolism protection is poised for further evaluation and exploration.
    Naturally, there is still much to explore regarding SS-31. Issues such as inter-individual variability in response, long-term performance, and interactions with other active substances remain to be addressed in future studies. Since the regulation of mitochondrial function involves the complex coordination of multiple mechanisms, more robust evidence is required to clarify the specific role SS-31 plays within this process. Only through comprehensive research and the establishment of a solid evidence base can its application value and prospects be accurately assessed—a process that reflects the fundamental scientific principles of incremental progress and an evidence-first approach.
    Overall, SS-31 demonstrates unique value in the field of energy metabolism and physiological maintenance, thanks to its ability to provide targeted protection for mitochondrial function, as well as its well-defined structure, precision targeting, and focused mechanism of action. It serves not only as a key subject for understanding the mechanisms of mitochondrial protection but also offers a highly promising avenue for exploring maintenance strategies centered on the energy core. By preserving mitochondrial structure, buffering oxidative stress, and maintaining energy production, SS-31 opens up new pathways for research into metabolic and physiological maintenance, while providing a vital reference and foundation for future developments in this field.

    Items Specifications
    Product Name SS-31(Elamipretide)
    Product name Peptide
    CAS NO
    736992-21-5
    Peptide Purity 99%
    Appearance Lyophilized Powder
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 1
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 2
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 3
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 4
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 5
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 6
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 7
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 8
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 9
    Shop SS-31, Elamipretide, Mitochondria-Targeting Peptide, Synthetic Peptide, Mitochondrial Function, Cellular Energy Metabolism, Antioxidant Peptide, Resea-Detailed Image 10
    ECHEMI Editorial Reference
    Elamipretide has been used in trials studying the treatment of Leber's Hereditary Optic Neuropathy.
    Elamipretide, also known as MTP 131, is a mitochondria-targeted peptide antioxidant. Elamipretide decreases inflammation and protect against a variety of neurological illnesses. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
    Elamipretide Synthetic is a single, non-glycosylated polypeptide chain containing 4 amino acids, having a molecular mass of 640 Dalton and a Molecular formula of C32H49N9O5 .

    Certificates
    • High  Quality SS-31 99% Purity, White Powder 10mg 50mg Anti fatigue, improve physical fitness Peptide Certificates 1 TDS

    Basic Info
    Product Name:

    Elamipretide

    Other Name:

    D-Arginyl-2,6-diMethyl-L-tyrosyl-L-lysyl-L-phenylalaninaMide;Elamipretide;L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-;Elamipretide (TFA salt);SS-31;MTP-131;BENDAVIA;Bendavia);Elamipretide (SS-31;ELAMIPRETIDE, >99%

    CAS No.:

    736992-21-5

    Molecular Formula:

    C32H49N9O5

    InChIKeys:

    SFVLTCAESLKEHH-WKAQUBQDSA-N

    Molecular Weight:

    639.79

    Exact Mass:

    639.38566570

    EC Number:

    205-858-1

    UNII:

    87GWG91S09

    DSSTox ID:

    DTXSID50471988

    Color/Form:

    White to Off-White

    Characteristics
    Density:

    1.34±0.1 g/cm3(Predicted)

    PKA:

    10.10±0.25(Predicted)

    Research
    Class:

    Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)

    Status:

    FDA-approved (Forzinity) — Accelerated Approval 2025

    Mechanism:

    A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.

    Activity note:

    SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.

    Source:

    Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI

    Clinical Development:

    NCT03098797; NCT02814097; NCT02976038; NCT03354065

    FDA:

    Forzinity (approved 2025-09-19)

    References
    ChEMBL:

    CHEMBL3833370

    DrugBank:

    DB11981

    KEGG DRUG:

    D10925

    PubChem:

    PubChem

    Disclaimer:

    Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

    Location:

    Room 1359, Room 103, Building Jia 19, Jixiang Garden, Tongzhou District, Beijing

    Year of Establishment:

    2026

  • Inquiry History
    105 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    SS-31 (Elamipretide MTP-131) CAS 736992-21-5 99% White Powder XO

    10  Oct 22, 2023
    United States

    SS-31

    500 MG Feb 20, 2026
    Philippines

    Elamipretide

    100 MG Mar 17, 2026
    Philippines

    Elamipretide / SS-31

    5 G Mar 16, 2026
    United States

    SS-31

    10 MG Oct 16, 2026
    United States

    SS31

    1 G Oct 15, 2026
    Kazakstan

    SS-31

    500 MG May 22, 2026
    Canada

    Ss31

    20 MG Oct 16, 2026
    Philippines

    SS-31

    30 MG Sep 15, 2026
    United States

    SS-31

    20 MG Aug 25, 2026
    United States

    SS31

    20 MG Aug 25, 2026
    United States

    Ss-31 Elamipretide

    1 PCS Aug 16, 2026
    Belgium

    Elamipretide SS-31

    50 MG Jun 18, 2026
    United States

    Elamipretide

    1 MG Jun 18, 2026
    United States

    Ss-31

    30 MG May 20, 2026
    United States

    SS-31

    50 MG May 19, 2026
    United States

    SS-31

    1 KG May 7, 2026
    United States

    SS-31 (elamipretide)

    450 MG May 3, 2026
    Russia

    SS-31 Elamipretide

    50 G Apr 3, 2026
    United States

    SS-31

    1 G Mar 30, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.